BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27109241)

  • 21. Microvolt T-wave alternans as predictor of electrophysiological testing results in professional competitive athletes.
    Furlanello F; Galanti G; Manetti P; Capalbo A; Pucci N; Michelucci A; Marangoni D; Terrasi F; Pettinati G; Cappato R
    Ann Noninvasive Electrocardiol; 2004 Jul; 9(3):201-6. PubMed ID: 15245334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure.
    Jackson CE; Myles RC; Tsorlalis IK; Dalzell JR; Rocchiccioli JP; Rodgers JR; Spooner RJ; Greenlaw N; Ford I; Gardner RS; Cobbe SM; Petrie MC; McMurray JJ
    Eur J Heart Fail; 2013 Nov; 15(11):1253-61. PubMed ID: 23703105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of microvolt T-wave alternans for cardiac death or ventricular tachyarrhythmic events in ischemic and nonischemic cardiomyopathy patients: a meta-analysis.
    Calò L; De Santo T; Nuccio F; Sciarra L; De Luca L; Stefano LM; Piroli E; Zuccaro L; Rebecchi M; de Ruvo E; Lioy E
    Ann Noninvasive Electrocardiol; 2011 Oct; 16(4):388-402. PubMed ID: 22008495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Evaluation of Microvolt T-Wave Alternans in Hypertrophic Cardiomyopathy: 9-year Clinical Follow-up.
    Antunes MO; Arteaga-Fernandez E; Samesima N; Pereira Filho HG; Matsumoto AY; Verrier RL; Pastore CA; Mady C
    Arq Bras Cardiol; 2023; 120(8):e20220833. PubMed ID: 37672406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scar tissue and microvolt T-wave alternans.
    Kraaier K; Olimulder MA; Galjee MA; van Dessel PF; van der Palen J; Wilde AA; Scholten MF
    Int J Cardiovasc Imaging; 2014 Apr; 30(4):773-9. PubMed ID: 24563008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence regarding clinical use of microvolt T-wave alternans.
    Hohnloser SH; Ikeda T; Cohen RJ
    Heart Rhythm; 2009 Mar; 6(3 Suppl):S36-44. PubMed ID: 19168396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis.
    Gupta A; Hoang DD; Karliner L; Tice JA; Heidenreich P; Wang PJ; Turakhia MP
    Am Heart J; 2012 Mar; 163(3):354-64. PubMed ID: 22424005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of microvolt T-wave alternans in high-risk patients with the congenital long-QT syndrome.
    Schmitt J; Baumann S; Klingenheben T; Richter S; Duray G; Hohnloser SH; Ehrlich JR
    Ann Noninvasive Electrocardiol; 2009 Oct; 14(4):340-5. PubMed ID: 19804510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular dysfunction in patients with suspected pulmonary arterial hypertension.
    Gavilanes F; Alves JL; Fernandes C; Prada LF; Jardim CV; Morinaga LT; Dias BA; Hoette S; Souza R
    J Bras Pneumol; 2014; 40(6):609-16. PubMed ID: 25610501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of microvolt T-wave alternans for predicting outcome in patients with Chagas disease with implantable cardioverter defibrillators.
    Barbosa MPT; da Costa Rocha MO; Neto ES; Brandão FV; Lombardi F; Ribeiro ALP
    Int J Cardiol; 2016 Nov; 222():80-85. PubMed ID: 27467316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Microvolt T-Wave Alternans and Malignant Ventricular Arrhythmias in Chagas Disease.
    Almeida BCS; Carmo AALD; Barbosa MPT; Silva JLPD; Ribeiro ALP
    Arq Bras Cardiol; 2018 May; 110(5):412-417. PubMed ID: 29641645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy.
    Baravelli M; Fantoni C; Rogiani S; Farina S; Anzà C; Caltabiano V; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2007 Sep; 121(1):23-9. PubMed ID: 17188766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy.
    Patel RK; Mark PB; Halliday C; Steedman T; Dargie HJ; Cobbe SM; Jardine AG
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):519-27. PubMed ID: 21088291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biventricular pacing does not affect microvolt T-wave alternans in heart failure patients.
    Ehrlich JR; Wegener FT; Anneken L; Duray G; Israel CW; Hohnloser SH
    Heart Rhythm; 2008 Mar; 5(3):348-52. PubMed ID: 18313590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvolt T-wave alternans predicts cardiac events after acute myocardial infarction in patients treated with primary percutaneous coronary intervention.
    Wita K; Filipecki A; Bochenek T; Tabor Z; Myszor J; Turski M; Doruchowska A; Trusz-Gluza M
    Adv Med Sci; 2012; 57(2):328-33. PubMed ID: 23183770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis.
    Chan PS; Gold MR; Nallamothu BK
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1009-14. PubMed ID: 20384655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.